TAMMY BRIGMAN-WALLACE: Open Payments
NPI 1578142543 · ROCKINGHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$159 in 9 payments from 7 companies in 2025. Trend: 2023 $350 · 2024 $390 · 2025 $159
Food & beverage: $159
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
| Amgen Inc. | 1 | $14 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, FARXIGA, NEXLETOL, VOQUEZNA, Rybelsus, OTEZLA, Kerendia.
Industry payments across NC — which companies pay providers there.
